A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Viatris Inc stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 138,728 shares of VTRS stock, worth $1.73 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
138,728
Previous 159,236 12.88%
Holding current value
$1.73 Million
Previous $1.69 Million 4.84%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$10.32 - $12.13 $211,642 - $248,762
-20,508 Reduced 12.88%
138,728 $1.61 Million
Q2 2024

Jul 26, 2024

SELL
$10.05 - $12.02 $32,943 - $39,401
-3,278 Reduced 2.02%
159,236 $1.69 Million
Q1 2024

Apr 24, 2024

SELL
$11.27 - $13.53 $57,206 - $68,678
-5,076 Reduced 3.03%
162,514 $1.94 Million
Q4 2023

Feb 09, 2024

SELL
$8.77 - $10.85 $104,810 - $129,668
-11,951 Reduced 6.66%
167,590 $1.82 Million
Q3 2023

Oct 24, 2023

BUY
$9.59 - $11.35 $50,107 - $59,303
5,225 Added 3.0%
179,541 $1.77 Million
Q2 2023

Jul 13, 2023

BUY
$9.02 - $10.29 $235,232 - $268,352
26,079 Added 17.59%
174,316 $1.74 Million
Q1 2023

May 11, 2023

BUY
$9.2 - $12.26 $26,532 - $35,357
2,884 Added 1.98%
148,237 $1.43 Million
Q4 2022

Feb 08, 2023

SELL
$8.72 - $11.56 $396,576 - $525,737
-45,479 Reduced 23.83%
145,353 $1.62 Million
Q3 2022

Oct 17, 2022

BUY
$8.48 - $11.13 $202,383 - $265,628
23,866 Added 14.29%
190,832 $1.63 Million
Q2 2022

Jul 13, 2022

BUY
$9.95 - $12.27 $47,600 - $58,699
4,784 Added 2.95%
166,966 $1.75 Million
Q1 2022

May 12, 2022

BUY
$9.81 - $15.4 $219,734 - $344,944
22,399 Added 16.02%
162,182 $1.76 Million
Q4 2021

Feb 03, 2022

SELL
$12.09 - $14.68 $40,658 - $49,368
-3,363 Reduced 2.35%
139,783 $1.89 Million
Q3 2021

Nov 02, 2021

SELL
$13.25 - $15.13 $792,800 - $905,288
-59,834 Reduced 29.48%
143,146 $1.94 Million
Q2 2021

Aug 10, 2021

SELL
$12.97 - $16.15 $81,308 - $101,244
-6,269 Reduced 3.0%
202,980 $2.9 Million
Q1 2021

May 07, 2021

BUY
$13.59 - $18.54 $37,141 - $50,669
2,733 Added 1.32%
209,249 $2.92 Million
Q4 2020

Feb 04, 2021

BUY
$14.3 - $18.74 $2.95 Million - $3.87 Million
206,516 New
206,516 $3.87 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.1B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.